» Articles » PMID: 37848443

Post-interventional Infectious Complications in Percutaneous Transabdominal Lymphatic Interventions: an Observational Study

Overview
Journal Sci Rep
Specialty Science
Date 2023 Oct 17
PMID 37848443
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this retrospective study was to evaluate the occurrence of infectious complications and inflammatory reactions after transabdominal lymphatic-interventions. 63 lymphatic-interventions were performed in 60 patients (male/female: 35/25; mean age 56 [9-85] years) [chylothorax n = 48, chylous ascites n = 7, combined chylothorax/chylous ascites n = 5]. Post-interventional clinical course and laboratory findings were analyzed in the whole cohort as well as subgroups without (group A; n = 35) and with peri-interventional antibiotics (group B; n = 25) (pneumonia n = 16, drainage-catheter inflammation n = 5, colitis n = 1, cystitis n = 1, transcolonic-access n = 2). No septic complications associated with the intervention occurred. Leucocytes increased significantly, peaking on post-interventional day-1 (8.6 ± 3.9 × 10 cells/mL vs. 9.8 ± 4.7 × 10 cells/mL; p = 0.009) and decreased thereafter (day-10: 7.3 ± 2.7 × 10 cells/mL, p = 0.005). CRP-values were pathological in 89.5% of patients already at baseline (40.1 ± 63.9 mg/L) and increased significant on day-3 (77.0 ± 78.8 mg/L, p < 0.001). Values decreased thereafter (day-15: 25.3 ± 34.4 mg/L, p = 0.04). In subgroup B, 13/25 patients had febrile episodes post-interventionally (pneumonia n = 11, cystitis n = 1, drainage-catheter inflammation n = 1). One patient developed biliary peritonitis despite continued antibiotics and underwent cholecystectomy. Baseline leucocytes and CRP-levels were higher in group B than A, but with comparable post-interventional profiles. Clinically relevant infectious complications associated with transabdominal lymphatic-interventions are rare irrespective of peri-interventional antibiotic use. Post-interventional elevation of leucocytes and CRP are observed with normalization over 10-15 days.

Citing Articles

Propranolol As a Treatment Option for Chylous Effusions and Chylous Ascites in Fetuses and Neonates: A Systematic Review.

Courteau B, Zarlenga G, Narciso-Owen S, Nemec Ii E, Rose S J Pediatr Pharmacol Ther. 2024; 29(5):468-474.

PMID: 39411407 PMC: 11472413. DOI: 10.5863/1551-6776-29.5.468.

References
1.
Chehab M, Thakor A, Tulin-Silver S, Connolly B, Cahill A, Ward T . Adult and Pediatric Antibiotic Prophylaxis during Vascular and IR Procedures: A Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian.... J Vasc Interv Radiol. 2018; 29(11):1483-1501.e2. DOI: 10.1016/j.jvir.2018.06.007. View

2.
Pieper C . Back to the Future II-A Comprehensive Update on the Rapidly Evolving Field of Lymphatic Imaging and Interventions. Invest Radiol. 2023; 58(8):610-640. DOI: 10.1097/RLI.0000000000000966. View

3.
Majdalany B, Khayat M, Downing T, Killoran T, El-Haddad G, Khaja M . Lymphatic interventions for isolated, iatrogenic chylous ascites: A multi-institution experience. Eur J Radiol. 2018; 109:41-47. DOI: 10.1016/j.ejrad.2018.10.019. View

4.
Pieper C, Schild H . Direct Cervical Puncture for Retrograde Thoracic Duct Embolization in a Postoperative Cervical Lymphatic Fistula. J Vasc Interv Radiol. 2015; 26(9):1405-8. DOI: 10.1016/j.jvir.2015.05.003. View

5.
Schild H, Naehle C, Wilhelm K, Kuhl C, Thomas D, Meyer C . Lymphatic Interventions for Treatment of Chylothorax. Rofo. 2015; 187(7):584-8. DOI: 10.1055/s-0034-1399438. View